PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
94.45
+1.75 (1.89%)
Nov 21, 2024, 4:00 PM EST - Market closed
PROCEPT BioRobotics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 199.84 | 136.19 | 75.01 | 34.47 | 7.72 | 6.17 |
| Revenue Growth (YoY) | 71.71% | 81.55% | 117.60% | 346.72% | 25.09% | - |
| Cost of Revenue | 85.16 | 65.14 | 37.93 | 18.61 | 8.97 | 8.05 |
| Gross Profit | 114.68 | 71.05 | 37.09 | 15.87 | -1.26 | -1.89 |
| Selling, General & Admin | 159.42 | 131.77 | 88.83 | 51.04 | 30.27 | 28.52 |
| Research & Development | 61.73 | 48.45 | 28.98 | 18.99 | 16.28 | 13.15 |
| Operating Expenses | 221.14 | 180.22 | 117.81 | 70.03 | 46.55 | 41.67 |
| Operating Income | -106.46 | -109.17 | -80.72 | -54.16 | -47.8 | -43.55 |
| Interest Expense | -4.34 | -4 | -5.18 | -5.81 | -5.26 | -0.72 |
| Interest & Investment Income | 10.99 | 7.55 | 2.5 | 0.08 | 0.18 | 1.15 |
| Other Non Operating Income (Expenses) | -0.25 | -0.28 | -0.49 | 0.05 | -0.14 | 1.15 |
| EBT Excluding Unusual Items | -100.06 | -105.9 | -83.9 | -59.85 | -53.02 | -41.98 |
| Other Unusual Items | - | - | -3.26 | - | - | - |
| Pretax Income | -100.06 | -105.9 | -87.15 | -59.85 | -53.02 | -41.98 |
| Net Income | -100.06 | -105.9 | -87.15 | -59.85 | -53.02 | -41.98 |
| Net Income to Common | -100.06 | -105.9 | -87.15 | -59.85 | -53.02 | -41.98 |
| Shares Outstanding (Basic) | 51 | 47 | 44 | 16 | 4 | 2 |
| Shares Outstanding (Diluted) | 51 | 47 | 44 | 16 | 4 | 2 |
| Shares Change (YoY) | 12.07% | 6.43% | 169.42% | 349.90% | 65.90% | - |
| EPS (Basic) | -1.95 | -2.24 | -1.96 | -3.63 | -14.47 | -19.01 |
| EPS (Diluted) | -1.95 | -2.24 | -1.96 | -3.63 | -14.47 | -19.01 |
| Free Cash Flow | -103.57 | -133.21 | -83.04 | -57.93 | -48.58 | -51.43 |
| Free Cash Flow Per Share | -2.02 | -2.82 | -1.87 | -3.51 | -13.26 | -23.29 |
| Gross Margin | 57.39% | 52.17% | 49.44% | 46.02% | -16.26% | -30.56% |
| Operating Margin | -53.27% | -80.16% | -107.61% | -157.12% | -619.44% | -705.95% |
| Profit Margin | -50.07% | -77.76% | -116.18% | -173.62% | -687.04% | -680.42% |
| Free Cash Flow Margin | -51.82% | -97.81% | -110.69% | -168.03% | -629.47% | -833.67% |
| EBITDA | -101.36 | -105.36 | -77.88 | -50.84 | -44.94 | -42.06 |
| EBITDA Margin | -50.72% | -77.36% | -103.82% | -147.48% | - | - |
| D&A For EBITDA | 5.1 | 3.81 | 2.84 | 3.32 | 2.86 | 1.49 |
| EBIT | -106.46 | -109.17 | -80.72 | -54.16 | -47.8 | -43.55 |
| EBIT Margin | -53.27% | -80.16% | -107.61% | -157.12% | - | - |
| Advertising Expenses | - | 0.3 | 0.1 | 0.1 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.